📰 Value Based Pricing News
Value Based Pricing News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Value Based Pricing. Real-time updates on events, politics, business and more.
November 6, 2023
Cantor Fitzgerald said it expects a “very strong product launch” of a gene therapy made by Krystal Biotech, the topical gel Vyjuvek which treats a rare skin disease.
February 21, 2023
/PRNewswire/ -- The "U.S. Real-World Evidence Solutions Market by Component, Application, End User - Forecast to 2029" report has been added to...
November 4, 2022
What is value-based pricing and is it right for your business? This comprehensive guide shares pros, cons, and examples to help you decide.
January 11, 2022
/PRNewswire/ -- The "Real-World Evidence (RWE) Solutions Market by Component (Datasets [Clinical, Claims, Pharmacy, Integrated], Services), Application (Market...
January 11, 2022
/PRNewswire/ -- The "Real-World Evidence (RWE) Solutions Market by Component (Datasets [Clinical, Claims, Pharmacy, Integrated], Services), Application (Market...
November 30, 2021
Discover the different B2B pricing models and strategies that will help you attract your target market and maximize revenue.
May 26, 2021
Marketingmanager at Netafim in Maasdijk
February 16, 2021
What Is the Right Price for Your Agency’s SEO Services? Written by Images by SEOMonitor. Used with permission. Whether or not your agency’s pricing is on point is a pressing question when dealing with a potential client. How many times have you found yourself thinking that you sold your agency short? Or been anxious that the client won’t accept your fee? Maybe you’ve been caught in endless and disappointing negotiations where the value was lost altogether. Pricing feels like a black box...
December 29, 2020
Share this article Share this article ResearchAndMarkets.coms offering. The real-world evidence solutions market is expected to grow at a CAGR of 16.5% from 2020 to 2027 to reach USD 3.13 billion by 2027. The growth in the real-world evidence solutions market is mainly attributed to the rising geriatric population and burden of chronic diseases, the shift towards value-based care, growing focus on personalized healthcare, delays in drug development and the subsequent increase in development co...